Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (600721.SS)
CNY 7.06
(0.28%)
CNY 7.06
(0.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 62.07 Million | 53.17 Million | 34.72 Million | -23.28 Million | -6.79 Million | 80.55 Million |
| Net Income | 12.97 Million | -34.72 Million | 59.87 Million | -319.76 Million | 33.76 Million | -812.97 Million |
| Depreciation & Amortization | 23.14 Million | 26.15 Million | 25.14 Million | 30.19 Million | 30.29 Million | 27.15 Million |
| Deferred income taxes | 2.86 Million | 2.45 Million | 3.18 Million | 4.43 Million | -2.25 Million | -138.7 Thousand |
| Stock-based compensation | 3.24 Million | 7.99 Million | 2.4 Million | - | - | - |
| Change in working capital | -31.23 Million | -7.87 Million | -74.49 Million | 104.67 Million | -101 Million | -59.26 Million |
| Other non-cash items | 1.89 Million | 59.17 Million | 18.61 Million | 161.61 Million | 30.14 Million | 925.64 Million |
| Investing Cash Flow | -15.65 Million | -10.55 Million | 297.32 Thousand | 33.62 Million | -44.16 Million | -103.38 Million |
| Investments in PPE | -17.23 Million | -2.4 Million | -6.03 Million | -3.77 Million | -25.84 Million | -56.02 Million |
| Acquisitions | 21.1 Thousand | 18 Thousand | 1390.00 | 4.02 Million | 2.89 Million | - |
| Investment purchases | -166.9 Million | -64 Million | -58.4 Million | -42.99 Million | -80.47 Million | -164.19 Million |
| Sales/Maturities of investments | 168.46 Million | 64.73 Million | 64.73 Million | 80.13 Million | 57.05 Million | 116.75 Million |
| Other Investing Activities | 1.58 Million | -8.89 Million | -0.61 | -3.77 Million | 2.19 Million | 69 Thousand |
| Financing Cash Flow | 19.91 Million | 6.22 Million | 6.25 Million | -15.85 Million | 1.7 Million | -1.97 Million |
| Debt repayment | - | -6.28 Million | -6.28 Million | -20 Million | -27.4 Million | -4.8 Million |
| Dividends payments | - | -120.55 Thousand | -39.23 Thousand | -751.58 Thousand | -893.75 Thousand | -1.04 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 19.91 Million | 12.63 Million | 12.57 Million | 4.89 Million | 29.99 Million | 3.86 Million |
| Accounts receivables | -34.26 Million | -49.84 Million | 7.01 Million | -76.5 Million | -42.6 Million | -189.66 Million |
| Accounts payables | - | 49.84 Million | -7.01 Million | 76.5 Million | 42.6 Million | - |
| Inventory | 4.21 Million | 2.5 Million | -16.72 Million | 41.31 Million | -76.74 Million | 52.46 Million |
| Other working capital | 3.24 Million | -10.38 Million | -57.77 Million | 63.35 Million | -24.26 Million | -111.72 Million |
| Cash at beginning of period | 135.73 Million | 86.88 Million | 45.61 Million | 51.12 Million | 100.37 Million | 125.19 Million |
| Cash at end of period | 202.07 Million | 135.73 Million | 86.88 Million | 45.61 Million | 51.12 Million | 100.37 Million |
| Capital Expenditure | -17.23 Million | -2.4 Million | -6.03 Million | -3.77 Million | -25.84 Million | -56.02 Million |
| Effect of forex changes on cash | - | - | 1.00 | - | 0.10 | 0.37 |
| Net cash flow / Change in cash | 66.33 Million | 48.84 Million | 41.26 Million | -5.5 Million | -49.25 Million | -24.81 Million |
| Free Cash Flow | 44.84 Million | 50.77 Million | 28.68 Million | -27.05 Million | -32.63 Million | 24.52 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.29 Million | 1.99 Million | 20.66 Million | -4.71 Million | 12.97 Million | 4.69 Million |
| Depreciation & Amortization | - | 4.93 Million | 4.93 Million | 23.14 Million | 23.14 Million | -11.29 Million |
| Deferred income taxes | - | - | - | - | 2.86 Million | -19.63 Million |
| Stock-based compensation | - | - | - | 3.24 Million | 3.24 Million | -4.73 Million |
| Change in working capital | - | - | - | -26.8 Million | -31.23 Million | 35.66 Million |
| Other non-cash items | 5.23 Million | 42.38 Million | -5.55 Million | 56.42 Million | 1.89 Million | 3.5 Million |
| Investing Cash Flow | -67.54 Million | 40.76 Million | -137.23 Million | 86.38 Million | -15.65 Million | -25.25 Million |
| Investments in PPE | -1.13 Million | -8.83 Million | -12.5 Million | -6.53 Million | -17.23 Million | -3.56 Million |
| Acquisitions | 23.02 Thousand | 660.00 | 41.5 Thousand | - | 21.1 Thousand | 600.00 |
| Investment purchases | -164.9 Million | -121.9 Million | -195.68 Million | -39.85 Million | -166.9 Million | -32.4 Million |
| Sales/Maturities of investments | 98.46 Million | 171.5 Million | 70.9 Million | 132.76 Million | 168.46 Million | 10.71 Million |
| Other Investing Activities | 23.01 Thousand | 660.00 | -124.73 Million | 92.91 Million | 1.58 Million | 0.30 |
| Financing Cash Flow | 4.77 Million | 820.45 Thousand | 756.33 Thousand | 3.57 Million | 19.91 Million | 13.58 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 4.77 Million | 820.45 Thousand | 756.33 Thousand | 3.57 Million | 19.91 Million | 13.58 Million |
| Accounts receivables | - | - | - | -34.26 Million | -34.26 Million | 29.03 Million |
| Accounts payables | - | - | - | - | - | 4.73 Million |
| Inventory | - | - | - | 4.21 Million | 4.21 Million | 6.62 Million |
| Other working capital | - | - | - | 3.24 Million | 3.24 Million | -4.73 Million |
| Cash at beginning of period | 161.73 Million | 80.69 Million | 202.07 Million | 64.05 Million | 135.73 Million | 67.83 Million |
| Cash at end of period | 105.22 Million | 161.73 Million | 80.69 Million | 202.07 Million | 202.07 Million | 64.05 Million |
| Capital Expenditure | -1.13 Million | -8.83 Million | -12.5 Million | -6.53 Million | -17.23 Million | -3.56 Million |
| Effect of forex changes on cash | - | - | - | - | - | -313.84 Thousand |
| Net cash flow / Change in cash | -56.51 Million | 81.03 Million | -121.37 Million | 138.01 Million | 66.33 Million | -3.78 Million |
| Free Cash Flow | 5.38 Million | 30.61 Million | 2.6 Million | 41.52 Million | 44.84 Million | 4.63 Million |
002958
600098
1815
PRYMF
EPLAS
BRN